Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE REVEAL RAPID AST SYSTEM AS AN ANTIBIOTIC SUSCEPTIBILITY DIAGNOSTIC TEST TYPE OF COUNTERMEASURE TO DETERMINE THE TREATMENT FOR LIFE THREATENING URGENT INFECTIONS FROM PATIENT is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Biofire Defense LLC. Estimated value $43.5M ($7.6M obligated). Current period of performance ends Dec 31, 2026. Last award drew 1 bidder. Place of performance: SALT LAKE CITY UT. Related solicitation BAA-18-100-SOL-00003.
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE REVEAL RAPID AST SYSTEM AS AN ANTIBIOTIC SUSCEPTIBILITY DIAGNOSTIC TEST TYPE OF COUNTERMEASURE TO DETERMINE THE TREATMENT FOR LIFE THREATENING URGENT INFECTIONS FROM PATIENT
Recompete timing
PublicCurrent PoP ends Dec 31, 2026 (132 days remaining). Agencies typically plan 12–18 months ahead — at 4.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordBiofire Defense LLC — $41.2M obligated across 235 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50122C00057?
75A50122C00057 (Overall objective of THIS contract IS) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $43.5M, currently held by Biofire Defense LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50122C00057?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50122C00057 to Biofire Defense LLC (potential $43.5M).
Who is the incumbent on 75A50122C00057?
Biofire Defense LLC is the incumbent with $41.2M across 235 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.
When does Biofire Defense LLC’s 75A50122C00057 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.